A Promise Beyond Cancer

Envisioning the future of targeted therapeutics

Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Focused on cell therapy and immune-oncology treatment, we are committed to improving the lives of millions of patients across the world who are suffering from a wide range of malignancies.


Inspired and ambitious, our researchers are pioneers in cancer research having made, what we believe to be one of the most exciting advances in targeted therapies, the discovery of nfP2X7 – a new oncology target which is shown to be present on the cell surface of a wide range of cancers, including lung, breast, colorectal and prostate.

We have several chimeric antigen receptor (CAR) T-cell and antibody programs in development that focus on nfP2X7 and, if successful, are one step closer to our vision of best-in-class targeted treatment for a great number of cancer patients.


News & Media

Go to Top